The most recent preliminary estimates of incidence rates and trends are for 2000-2017. Users should refer to the official rates for 1975-2018 in SEER*Explorer, which was released in April 2021.

Based on results from the February 2019 SEER submission of cases for 2017 rates and trends, the following figures and tables are presented. Caution is advised when interpreting these figures and tables, as these are preliminary results and are subject to change for 2017 with the addition of data from more recent case submissions.

Data are also available for download for use in your own software.

Preliminary 5-year Average Annual Percent Change (AAPC) Estimates
Based on Joinpoint Analyses 2000-2017

February 2019 SEER Submission, SEER 18 Registries

Preliminary 5-year AAPC Estimates
Male, All Races

Preliminary 5-year AAPC Estimates
Female, All Races

Preliminary 5-year AAPC Estimates
Male, White

Preliminary 5-year AAPC Estimates
Female, White

Preliminary 5-year AAPC Estimates
Male, Black

Preliminary 5-year AAPC Estimates
Female, Black

The graph above presents the Average Annual Percent Change (What is an AAPC?) for 2013-2017 based on the preliminary rates through 2017.
The Joinpoint analyses on the series allowed up to 3 Joinpoints in the trend.
The underlying rates in the analysis were adjusted for reporting delay in the registry.
* The AAPC is significantly different from zero (p<.05).

5-year Delay-Adjusted Ratesa

February 2019 SEER Submission (2000-2017), SEER 18 Registries

Cancer Site Sex Race Delay-adjusted rates a 2013-2017
All SitesMaleAll Races476.6
White484.6
Black528.7
FemaleAll Races416.0
White431.9
Black407.4
All Sites (Ages 0-19)MaleAll Races19.3
White20.6
Black14.1
FemaleAll Races18.0
White19.1
Black13.8
Brain and Other Nervous SystemMaleAll Races7.6
White8.3
Black4.7
FemaleAll Races5.4
White6.0
Black3.5
BreastFemaleAll Races127.3
White129.8
Black129.1
CervixFemaleAll Races7.5
White7.5
Black8.3
Colon and RectumMaleAll Races44.1
White43.5
Black53.4
FemaleAll Races34.0
White33.7
Black40.7
Corpus and Uterus NOSFemaleAll Races26.8
White27.4
Black26.5
EsophagusMaleAll Races7.1
White7.6
Black6.1
FemaleAll Races1.7
White1.7
Black2.1
Hodgkin LymphomaMaleAll Races2.8
White3.0
Black3.0
FemaleAll Races2.2
White2.4
Black2.2
Kidney and Renal PelvisMaleAll Races22.5
White23.1
Black25.9
FemaleAll Races11.3
White11.7
Black13.3
LarynxMaleAll Races4.9
White4.9
Black7.9
FemaleAll Races1.0
White1.1
Black1.5
LeukemiaMaleAll Races18.9
White20.4
Black14.9
FemaleAll Races11.5
White12.3
Black9.7
Liver and Intrahepatic Bile DuctMaleAll Races14.1
White12.8
Black17.9
FemaleAll Races5.0
White4.6
Black5.4
Lung and BronchusMaleAll Races61.0
White61.2
Black77.0
FemaleAll Races47.1
White49.7
Black47.0
Melanoma of the SkinMaleAll Races30.8
White36.9
Black1.2
FemaleAll Races18.6
White22.9
Black0.9
MyelomaMaleAll Races9.0
White8.5
Black17.6
FemaleAll Races5.8
White5.1
Black12.9
Non-Hodgkin LymphomaMaleAll Races23.8
White25.1
Black18.0
FemaleAll Races16.1
White17.0
Black12.5
Oral Cavity and PharynxMaleAll Races17.5
White18.5
Black14.1
FemaleAll Races6.4
White6.7
Black5.1
OvaryFemaleAll Races11.2
White11.7
Black9.3
PancreasMaleAll Races14.7
White14.8
Black17.6
FemaleAll Races11.5
White11.4
Black14.6
ProstateMaleAll Races108.4
White102.7
Black177.0
StomachMaleAll Races9.6
White8.7
Black13.5
FemaleAll Races5.2
White4.6
Black7.2
TestisMaleAll Races5.9
White7.1
Black1.6
ThyroidMaleAll Races7.4
White8.0
Black3.9
FemaleAll Races21.5
White22.9
Black13.5
Urinary BladderMaleAll Races33.6
White37.0
Black20.5
FemaleAll Races8.2
White8.9
Black6.9

aRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130).

Joinpoint Trend Analyses

November 2018 SEER Submission (2000-2016) and
February 2019 SEER Submission (2000-2017)
SEER 18 Registries

The numbers presented in the table below represent the Annual Percent Change (APC) in incidence rates. An APC is estimated based on a model that fits a linear trend to the log of the annual incidence rate. This model also estimates whether a trend changes significantly in direction or magnitude and, if it does, determines when the change(s) occurs. If a trend does not change over time, then there is only one estimate provided for the entire time period. If there is one or more points where a trend changes, the table shows each APC estimate and the years for which each estimate applies. The analyses allowed up to 3 changes (joinpoints) to occur in the trend.For more information about the model used to estimate these trends, visit Joinpoint Trend Analysis Software.

Cancer Site Sex Race November 2018 Submission
Joinpoint Trends
February 2019 Submission
Preliminary Joinpoint Trends
Annual Percent Change, 2000-2016
APC (Year Range)
Average Annual Percent Change,
2012-2016
Annual Percent Change, 2000-2017
APC (Year Range)
Average Annual Percent Change,
2013-2017
All SitesMaleAll Races-0.7* (2000-08)
-2.0* (2008-16)
-2.0*-0.8* (2000-08)
-1.8* (2008-17)
-1.8*
White-0.6* (2000-08)
-1.9* (2008-16)
-1.9*-0.7* (2000-08)
-1.8* (2008-17)
-1.8*
Black-1.8* (2000-06)
-0.2 (2006-09)
-3.7* (2009-14)
-0.2 (2014-16)
-1.9*-1.9* (2000-17)-1.9*
FemaleAll Races-0.1 (2000-16)-0.1-0.8* (2000-05)
0.9 (2005-08)
-0.1 (2008-17)
-0.1
White0.0 (2000-16)0.0-1.1 (2000-03)
0.1 (2003-17)
0.1
Black0.1 (2000-16)0.10.1 (2000-17)0.1
All Sites (Ages 0-19)MaleAll Races0.7* (2000-16)0.7*0.7* (2000-17)0.7*
White0.6* (2000-16)0.6*0.6* (2000-17)0.6*
Black1.3* (2000-16)1.3*1.1* (2000-17)1.1*
FemaleAll Races1.2* (2000-16)1.2*1.1* (2000-17)1.1*
White1.1* (2000-16)1.1*1.1* (2000-17)1.1*
Black1.4* (2000-16)1.4*1.4* (2000-17)1.4*
Brain and Other Nervous SystemMaleAll Races-0.3* (2000-16)-0.3*-0.2* (2000-17)-0.2*
White-0.2 (2000-16)-0.2-0.2 (2000-17)-0.2
Black-0.2 (2000-16)-0.2-0.1 (2000-17)-0.1
FemaleAll Races-0.3 (2000-16)-0.3-0.3* (2000-17)-0.3*
White-0.2 (2000-16)-0.2-0.1 (2000-17)-0.1
Black-0.6 (2000-16)-0.6-0.5 (2000-17)-0.5
BreastFemaleAll Races-2.3* (2000-04)
0.3* (2004-16)
0.3*-2.4* (2000-04)
0.3* (2004-17)
0.3*
White-2.5* (2000-04)
0.2 (2004-16)
0.2-2.6* (2000-04)
0.2 (2004-17)
0.2
Black0.6* (2000-16)0.6*0.6* (2000-17)0.6*
CervixFemaleAll Races-3.8* (2000-03)
-1.5* (2003-13)
1.2 (2013-16)
0.5-4.0* (2000-03)
-1.4* (2003-13)
0.7 (2013-17)
0.7
White-4.8* (2000-03)
-0.1 (2003-08)
-2.2* (2008-13)
2.8* (2013-16)
1.5*-4.7* (2000-03)
-0.6* (2003-17)
-0.6*
Black-2.7* (2000-16)-2.7*-2.6* (2000-17)-2.6*
Colon and RectumMaleAll Races-2.5* (2000-08)
-4.1* (2008-11)
-1.4* (2011-16)
-1.4*-2.6* (2000-17)-2.6*
White-3.0* (2000-12)
-1.4 (2012-16)
-1.4-3.0* (2000-12)
-1.5* (2012-17)
-1.5*
Black-2.5* (2000-16)-2.5*-2.5* (2000-17)-2.5*
FemaleAll Races-2.1* (2000-08)
-3.0* (2008-13)
-0.2 (2013-16)
-0.9-2.2* (2000-17)-2.2*
White-2.4* (2000-13)
-0.2 (2013-16)
-0.8-2.4* (2000-13)
-0.5 (2013-17)
-0.5
Black-1.3* (2000-06)
-2.9* (2006-16)
-2.9*-2.4* (2000-17)-2.4*
Corpus and Uterus NOSFemaleAll Races-1.5 (2000-03)
1.5* (2003-16)
1.5*-1.7 (2000-03)
1.5* (2003-17)
1.5*
White-1.9 (2000-03)
1.3* (2003-16)
1.3*-2.0 (2000-03)
1.3* (2003-17)
1.3*
Black2.4* (2000-16)2.4*2.3* (2000-17)2.3*
EsophagusMaleAll Races-1.0* (2000-16)-1.0*-0.9* (2000-17)-0.9*
White-0.4* (2000-16)-0.4*-0.3* (2000-17)-0.3*
Black-4.7* (2000-16)-4.7*-4.6* (2000-17)-4.6*
FemaleAll Races-1.6* (2000-16)-1.6*-1.6* (2000-17)-1.6*
White-1.0* (2000-16)-1.0*-1.0* (2000-17)-1.0*
Black-3.9* (2000-16)-3.9*-3.8* (2000-17)-3.8*
Hodgkin LymphomaMaleAll Races1.0 (2000-07)
-1.5* (2007-16)
-1.5*1.1 (2000-07)
-1.7* (2007-17)
-1.7*
White1.1 (2000-07)
-1.7* (2007-16)
-1.7*1.1 (2000-07)
-1.9* (2007-17)
-1.9*
Black0.3 (2000-16)0.30.0 (2000-17)0.0
FemaleAll Races2.3 (2000-05)
-1.6* (2005-16)
-1.6*2.9 (2000-04)
-1.3* (2004-17)
-1.3*
White2.1 (2000-05)
-1.7* (2005-16)
-1.7*1.0 (2000-07)
-1.8* (2007-17)
-1.8*
Black0.3 (2000-16)0.30.2 (2000-17)0.2
Kidney and Renal PelvisMaleAll Races3.0* (2000-08)
0.5* (2008-16)
0.5*2.4* (2000-05)
4.3* (2005-08)
-0.8 (2008-11)
1.1* (2011-17)
1.1*
White2.9* (2000-08)
0.6* (2008-16)
0.6*2.9* (2000-08)
0.6* (2008-17)
0.6*
Black3.4* (2000-08)
0.4 (2008-16)
0.43.2* (2000-09)
0.0 (2009-17)
0.0
FemaleAll Races3.6* (2000-07)
0.5 (2007-16)
0.53.5* (2000-07)
0.7* (2007-17)
0.7*
White4.1* (2000-06)
0.7* (2006-16)
0.7*4.0* (2000-06)
0.9* (2006-17)
0.9*
Black4.0* (2000-08)
0.8 (2008-16)
0.81.2 (2000-05)
7.9 (2005-08)
0.2 (2008-17)
0.2
LarynxMaleAll Races-4.4* (2000-03)
-1.7* (2003-10)
-3.3* (2010-16)
-3.3*-4.5* (2000-03)
-1.8* (2003-11)
-3.6* (2011-17)
-3.6*
White-2.3* (2000-16)-2.3*-4.2* (2000-03)
-1.5* (2003-11)
-3.7* (2011-17)
-3.7*
Black-3.3* (2000-16)-3.3*-3.2* (2000-17)-3.2*
FemaleAll Races-2.1* (2000-16)-2.1*-2.2* (2000-17)-2.2*
White-2.0* (2000-16)-2.0*-2.1* (2000-17)-2.1*
Black-1.7* (2000-16)-1.7*-1.8* (2000-17)-1.8*
LeukemiaMaleAll Races-0.5 (2000-07)
3.0 (2007-10)
0.4 (2010-16)
0.4-0.7 (2000-06)
2.0* (2006-12)
-0.1 (2012-17)
-0.1
White-0.1 (2000-06)
1.4* (2006-16)
1.4*-0.4 (2000-06)
1.8* (2006-13)
-0.2 (2013-17)
-0.2
Black0.5 (2000-16)0.50.5 (2000-17)0.5
FemaleAll Races0.8* (2000-16)0.8*0.9* (2000-17)0.9*
White1.0* (2000-16)1.0*1.0* (2000-17)1.0*
Black-1.2 (2000-07)
2.2* (2007-16)
2.2*-1.6* (2000-07)
3.3* (2007-12)
0.4 (2012-17)
0.4
Liver and Intrahepatic Bile DuctMaleAll Races4.2* (2000-09)
2.3* (2009-14)
-1.4 (2014-16)
0.41.4 (2000-02)
4.8* (2002-08)
2.3* (2008-15)
-2.1 (2015-17)
0.1
White-0.8 (2000-02)
7.6* (2002-05)
3.6* (2005-14)
-2.2 (2014-16)
0.60.2 (2000-02)
5.6* (2002-08)
3.1* (2008-14)
-0.3 (2014-17)
0.6
Black3.1* (2000-16)3.1*3.5* (2000-15)
-5.2 (2015-17)
-0.9
FemaleAll Races2.9* (2000-16)2.9*3.0* (2000-17)3.0*
White-0.3 (2000-03)
4.3* (2003-14)
-0.8 (2014-16)
1.70.2 (2000-03)
3.9* (2003-17)
3.9*
Black3.2* (2000-16)3.2*2.9* (2000-17)2.9*
Lung and BronchusMaleAll Races-1.9* (2000-08)
-3.1* (2008-16)
-3.1*-2.0* (2000-08)
-2.9* (2008-17)
-2.9*
White-1.8* (2000-08)
-3.1* (2008-16)
-3.1*-1.9* (2000-08)
-2.9* (2008-17)
-2.9*
Black-2.8* (2000-16)-2.8*-2.8* (2000-17)-2.8*
FemaleAll Races0.1 (2000-07)
-1.7* (2007-16)
-1.7*0.0 (2000-07)
-1.5* (2007-17)
-1.5*
White0.1 (2000-07)
-1.7* (2007-16)
-1.7*0.0 (2000-07)
-1.5* (2007-17)
-1.5*
Black1.2* (2000-06)
-1.8* (2006-16)
-1.8*0.4 (2000-08)
-1.9* (2008-17)
-1.9*
Melanoma of the SkinMaleAll Races1.8* (2000-16)1.8*2.0* (2000-15)
-2.4 (2015-17)
-0.2
White2.0* (2000-16)2.0*2.2* (2000-15)
-2.8 (2015-17)
-0.3
Black-0.9 (2000-16)-0.9-0.5 (2000-17)-0.5
FemaleAll Races1.4* (2000-16)1.4*1.4* (2000-17)1.4*
White1.7* (2000-16)1.7*3.0* (2000-05)
0.6 (2005-12)
4.6 (2012-15)
-3.0 (2015-17)
0.7
Black0.2 (2000-16)0.2-0.1 (2000-17)-0.1
MyelomaMaleAll Races1.7* (2000-16)1.7*0.4 (2000-06)
2.8* (2006-12)
0.7 (2012-17)
0.7
White1.6* (2000-16)1.6*1.6* (2000-17)1.6*
Black1.6* (2000-16)1.6*1.6* (2000-17)1.6*
FemaleAll Races-0.1 (2000-06)
2.1* (2006-16)
2.1*-0.1 (2000-06)
2.0* (2006-17)
2.0*
White0.0 (2000-07)
2.1* (2007-16)
2.1*-0.3 (2000-06)
2.0* (2006-17)
2.0*
Black2.0* (2000-16)2.0*2.0* (2000-17)2.0*
Non-Hodgkin LymphomaMaleAll Races0.8* (2000-07)
-0.3* (2007-16)
-0.3*0.7* (2000-08)
-0.4* (2008-17)
-0.4*
White0.9* (2000-07)
-0.3* (2007-16)
-0.3*0.9* (2000-07)
-0.3* (2007-17)
-0.3*
Black0.1 (2000-16)0.10.0 (2000-17)0.0
FemaleAll Races1.0 (2000-04)
-0.4* (2004-16)
-0.4*-0.1 (2000-17)-0.1
White0.6 (2000-06)
-0.4* (2006-16)
-0.4*-0.1 (2000-17)-0.1
Black0.3 (2000-16)0.30.4* (2000-17)0.4*
Oral Cavity and PharynxMaleAll Races-0.5 (2000-05)
1.0* (2005-16)
1.0*-0.5 (2000-05)
0.9* (2005-17)
0.9*
White1.1* (2000-16)1.1*-0.2 (2000-05)
1.5* (2005-15)
-1.5 (2015-17)
0.0
Black-4.4* (2000-05)
-1.3* (2005-16)
-1.3*-4.9* (2000-05)
-1.0* (2005-17)
-1.0*
FemaleAll Races0.1 (2000-16)0.10.2 (2000-17)0.2
White0.4* (2000-16)0.4*0.4* (2000-17)0.4*
Black-0.9* (2000-16)-0.9*-1.0* (2000-17)-1.0*
OvaryFemaleAll Races-1.5* (2000-16)-1.5*-1.6* (2000-17)-1.6*
White-1.6* (2000-16)-1.6*-1.7* (2000-17)-1.7*
Black-0.8* (2000-16)-0.8*-0.8* (2000-17)-0.8*
PancreasMaleAll Races0.8* (2000-16)0.8*0.9* (2000-17)0.9*
White1.0* (2000-16)1.0*1.0* (2000-17)1.0*
Black0.2 (2000-16)0.20.3 (2000-17)0.3
FemaleAll Races0.8* (2000-16)0.8*0.9* (2000-17)0.9*
White1.0* (2000-16)1.0*1.0* (2000-17)1.0*
Black0.1 (2000-16)0.10.2 (2000-17)0.2
ProstateMaleAll Races-1.8* (2000-10)
-9.0* (2010-14)
3.9 (2014-16)
-2.7-1.8* (2000-10)
-8.8* (2010-14)
3.5 (2014-17)
0.3
White-1.9* (2000-10)
-9.4* (2010-14)
4.0 (2014-16)
-2.9-1.9* (2000-10)
-9.2* (2010-14)
3.3 (2014-17)
0.0
Black-2.1* (2000-11)
-9.6* (2011-14)
4.0 (2014-16)
-3.0-2.1* (2000-11)
-9.2 (2011-14)
2.9 (2014-17)
-0.2
StomachMaleAll Races-1.4* (2000-16)-1.4*-1.4* (2000-17)-1.4*
White-1.1* (2000-16)-1.1*-1.1* (2000-17)-1.1*
Black-0.8 (2000-08)
-8.1 (2008-11)
2.6 (2011-14)
-5.7 (2014-16)
-1.6-2.3* (2000-17)-2.3*
FemaleAll Races-0.5* (2000-16)-0.5*-0.5* (2000-17)-0.5*
White-0.2 (2000-16)-0.2-0.2 (2000-17)-0.2
Black-1.7* (2000-16)-1.7*-1.8* (2000-17)-1.8*
TestisMaleAll Races0.8* (2000-16)0.8*0.8* (2000-17)0.8*
White0.8* (2000-16)0.8*0.8* (2000-17)0.8*
Black1.2 (2000-16)1.21.1 (2000-17)1.1
ThyroidMaleAll Races5.7* (2000-11)
1.0 (2011-16)
1.06.2* (2000-09)
2.7* (2009-15)
-3.7 (2015-17)
-0.5
White6.1* (2000-10)
1.5* (2010-16)
1.5*6.3* (2000-09)
2.6* (2009-15)
-3.3 (2015-17)
-0.4
Black3.6* (2000-16)3.6*4.4* (2000-14)
-5.7 (2014-17)
-3.3
FemaleAll Races6.9* (2000-09)
2.4* (2009-14)
-1.8 (2014-16)
0.36.3* (2000-06)
8.0* (2006-09)
1.9* (2009-15)
-5.4* (2015-17)
-1.8*
White7.1* (2000-09)
2.3* (2009-14)
-1.6 (2014-16)
0.37.1* (2000-09)
2.1* (2009-15)
-5.6* (2015-17)
-1.9*
Black5.7* (2000-14)
-4.5 (2014-16)
0.55.8* (2000-14)
-6.0* (2014-17)
-3.2
Urinary BladderMaleAll Races0.0 (2000-07)
-1.5* (2007-16)
-1.5*0.0 (2000-07)
-1.4* (2007-17)
-1.4*
White0.0 (2000-07)
-1.4* (2007-16)
-1.4*0.0 (2000-07)
-1.3* (2007-17)
-1.3*
Black-0.1 (2000-16)-0.1-0.2 (2000-17)-0.2
FemaleAll Races-1.0* (2000-16)-1.0*-1.1* (2000-17)-1.1*
White-0.9* (2000-16)-0.9*-1.0* (2000-17)-1.0*
Black-0.7* (2000-16)-0.7*-0.8* (2000-17)-0.8*
* The APC/AAPC is significantly different from zero (p<.05).